Are community health centers' chief executive officers' compensation related to clinical performance?


Journal

Health care management review
ISSN: 1550-5030
Titre abrégé: Health Care Manage Rev
Pays: United States
ID NLM: 7611530

Informations de publication

Date de publication:
Historique:
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 24 11 2021
Statut: ppublish

Résumé

Most research of chief executive officer (CEO) compensation in the health care industry has been limited to hospitals. This study expands our knowledge of CEO compensation into the nonhospital areas of the industry, specifically community health centers (CHCs). CHCs are safety-net providers that are an integral part of the U.S. health delivery system for medically underserved populations. Since the passage of the Patient Protection and Affordable Care Act, the federal government has created financial incentives for CHCs to improve care through access and quality performance criteria. To promote quality improvement, CEOs need to set their organization's priorities. One method used to achieve this goal is to tie the CEO's compensation to the organization's quality performance. However, there is a gap in our knowledge if CHCs' CEOs compensation is associated with quality performance outcomes. The primary aim of this study was to examine the relationship between clinical performance and CEO compensation in CHCs. Agency, social comparison, and managerial power theories guided this research, which examines the relationship of clinical performance and CEO compensation. Secondary data on Uniform Data System's CHC clinical performance combined with CEO compensation from Internal Revenue Service Form 990 were analyzed using generalized estimating equations with state and year fixed effects on a national sample of section 330 grant-funded CHCs (N = 984) for the period 2011-2016. We found no evidence that clinical performance was associated with CHCs' CEO compensation. Except for race, all other CEO characteristics were positively associated with CEO compensation and in line with previous research. We found that non-White CEOs were compensated more than White CEOs. In addition, further subanalyses revealed that an increase in the highest paid employees' compensation was associated with an increase in CEO compensation. The findings of this study can assist Health Resources and Services Administration improve its assessment policies in funding allocation to CHCs, as well as help board members make informed decisions regarding tying CEO compensation to predetermined performance metrics.

Sections du résumé

BACKGROUND
Most research of chief executive officer (CEO) compensation in the health care industry has been limited to hospitals. This study expands our knowledge of CEO compensation into the nonhospital areas of the industry, specifically community health centers (CHCs). CHCs are safety-net providers that are an integral part of the U.S. health delivery system for medically underserved populations. Since the passage of the Patient Protection and Affordable Care Act, the federal government has created financial incentives for CHCs to improve care through access and quality performance criteria. To promote quality improvement, CEOs need to set their organization's priorities. One method used to achieve this goal is to tie the CEO's compensation to the organization's quality performance. However, there is a gap in our knowledge if CHCs' CEOs compensation is associated with quality performance outcomes.
PURPOSE
The primary aim of this study was to examine the relationship between clinical performance and CEO compensation in CHCs.
METHODS/APPROACH
Agency, social comparison, and managerial power theories guided this research, which examines the relationship of clinical performance and CEO compensation. Secondary data on Uniform Data System's CHC clinical performance combined with CEO compensation from Internal Revenue Service Form 990 were analyzed using generalized estimating equations with state and year fixed effects on a national sample of section 330 grant-funded CHCs (N = 984) for the period 2011-2016.
RESULTS
We found no evidence that clinical performance was associated with CHCs' CEO compensation. Except for race, all other CEO characteristics were positively associated with CEO compensation and in line with previous research. We found that non-White CEOs were compensated more than White CEOs. In addition, further subanalyses revealed that an increase in the highest paid employees' compensation was associated with an increase in CEO compensation.
PRACTICE IMPLICATIONS
The findings of this study can assist Health Resources and Services Administration improve its assessment policies in funding allocation to CHCs, as well as help board members make informed decisions regarding tying CEO compensation to predetermined performance metrics.

Identifiants

pubmed: 33630508
doi: 10.1097/HMR.0000000000000255
pii: 00004010-202104000-00008
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162-171

Informations de copyright

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Références

Aggarwal R. K., Evans M. E., Nanda D. (2012). Nonprofit boards: Size, performance and managerial incentives. Journal of Accounting and Economics, 53(1), 466–487.
Ballou J. P., Weisbrod B. A. (2003). Managerial rewards and the behavior of for-profit, governmental, and nonprofit organizations: Evidence from the hospital industry. Journal of Public Economics, 87(9), 1895–1920.
Bebchuk L. A., Fried J. M., Walker D. I. (2002). Managerial power and rent extraction in the design of executive compensation. University of Chicago Law Review, 69(3), 751–846.
Blau F. D., Kahn L. M. (2017). The gender wage gap: Extent, trends, and explanations. Journal of Economic Literature, 55(3), 789–865.
Borkowski N. (2015). Organizational behavior, theory, and design in health care. Burlington, MA: Jones & Bartlett Publishers.
Brickley J. A., Van Horn R. L., Wedig G. J. (2010). Board composition and nonprofit conduct: Evidence from hospitals. Journal of Economic Behavior and Organization, 76(2), 196–208.
Briody B. (2013). 10 Insanely overpaid nonprofit execs. Huffington Post. Retrieved from http://www.huffingtonpost.com/2013/04/08/10-insanely-overpaid-nonp_n_3038162.html
Bruce A., Buck T., Main B. G. M. (2005). Top executive remuneration: A view from Europe. Journal of Management Studies, 42(7), 1493–1506.
Cable D., Vermeulen F. (2016). Stop paying executives for performance. Harvard Business Review. Retrieved from https://hbr.org/2016/02/stop-paying-executives-for-performance
Cardinaels E. (2009). Governance in non-for-profit hospitals: Effects of board members' remuneration and expertise on CEO compensation. Health Policy, 93(1), 64–75.
Carreyrou J., Martinez B. (2008). Nonprofit hospitals, once for the poor, strike it rich. Wall Street Journal, 10.
Coffman S. (2017). Highlights of the 2017 GuideStar Nonprofit Compensation Report. Retrieved from https://trust.guidestar.org/highlights-of-the-2017-guidestar-nonprofit-compensation-report
Deckop J. R., Merriman K. K., Gupta S. (2006). The effects of CEO pay structure on\ corporate social performance. Journal of Management, 32(3), 329–342.
Dhole S., Khumawala S. B., Mishra S., Ranasinghe T. (2015). Executive compensation and regulation-imposed governance: Evidence from the California Nonprofit Integrity Act of 2004. Accounting Review, 90(2), 443–466.
Du J. Y., Rascoe A. S., Marcus R. E. (2018). The growing executive-physician wage gap in major US nonprofit hospitals and burden of nonclinical workers on the US healthcare system. Clinical Orthopaedics and Related Research, 476(10), 1910–1919.
Eichmann T., Santerre R. (2011). Do hospital chief executive officers extract rents from certificate of need laws. Journal of Health Care Finance, 37(4), 1–14.
Eisenhardt K. M. (1989). Agency theory: An assessment and review. Academy of Management Review, 14(1), 57–74.
Evans M. (2014). Bonuses still tied to better financials. Use of CEO pay incentives for quality is uneven across for-profit hospital systems. Modern Healthcare, 44(17), 12–15.
Fama E. F., Jensen M. C. (1983). Separation of ownership and control. The Journal of Law and Economics, 26(2), 301–325.
Festinger L. (1954). A theory of social comparison processes. Human Relations, 7(2), 117–140.
Frumkin P., Keating E. K. (2010). The price of doing good: Executive compensation in nonprofit organizations. Policy and Society, 29, 269–282.
Gaver J. J., Im S. M. (2014). Funding sources and excess CEO compensation in not-for-profit organizations. Accounting Horizons, 28(1), 1–16.
Gayle G. L., Golan L., Miller R. A. (2015). Promotion, turnover, and compensation in the executive labor market. Econometrica, 83(6), 2293–2369.
Joshi M. S., Hines S. C. (2006). Getting the board on board: Engaging hospital boards in quality and patient safety. The Joint Commission Journal on Quality and Patient Safety, 32(4), 179–187.
Joynt K. E., Le S. T., Orav E. J., Jha A. K. (2014). Compensation of chief executive officers at nonprofit US hospitals. JAMA Internal Medicine, 174(1), 61–67.
Kahneman D., Slovic P., Tversky A. (1982). Judgement under uncertainty: Heuristics and biases ( ed., pp. 3–20). Cambridge, United Kingdom: Cambridge University Press.
Kay I. T., Van Putten S. (2007). Myths and realities of executive pay. Cambridge, United Kingdom: Cambridge University Press.
Kramer J., Santerre R. E. (2010). Not-for-profit hospital CEO performance and pay: Some evidence from Connecticut. Inquiry, 47(3), 242–251.
McKinney M. (2015). Dedicated panel sets executive pay. Modern Healthcare, 45(5), 32.
Nicks D. (2016). CEOs make 335 times what workers earn. Retrieved from http://time.com/money/4339078/ceo-pay-compare-workers/. Time.
Ozdemir O., Upneja A. (2012). Board structure and CEO compensation: Evidence from U.S. lodging industry. International Journal of Hospitality Management, 31(3), 856–863.
Pink G. H., Leatt P. (1990). Are managers compensated for hospital financial performance?Health Care Management Review, 16(3), 37–45.
Reiter K. L., Sandoval G. A., Brown A. D., Pink G. H. (2009). CEO compensation and hospital financial performance. Medical Care Research and Review, 66(6), 725–738.
Sandler M. (2015). CEO pay soars at top not-for-profits. Modern Healthcare, 45(32), 17.
Santerre R. E., Thomas J. M. (1993). The determinants of hospital CEO compensation. Health Care Management Review, 18(3), 31–40.
Selvam A. (2013). Sustained efforts to increase minority representation in healthcare executive ranks are delivering results, but barriers still remain. Modern Healthcare. Retrieved from http://www.modernhealthcare.com/article/20130518/MAGAZINE/305189958
Shay P. D., White K. R. (2014). Executive compensation in health care: A systematic review. Health Care Management Review, 39(3), 255–267.
Tillman K. (2009). An application of the principal-agent theory: Not-for-profit hospitals. Claremont, CA: Claremont Graduate University.
Tosi H. L., Werner S., Katz J. P., Gomez-Mejia L. R. (2000). How much does performance matter? A meta-analysis of CEO pay studies. Journal of Management, 26(2), 301–339.
Wiggenhorn J., Pissaris S., Gleason K. C. (2014). Powerful CEOs and employee relations: Evidence from corporate social responsibility indicators. Journal of Economics and Finance, 40(1), 85–104.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH